The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

There is growing appetite in Silicon Valley for the legally murky and morally frowned upon practice of embryo-editing. This is how it would work: Companies would use existing gene-editing technology ...

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory ...

A new regulatory framework, which allows the commercial cultivation of gene-edited crops in England, has cleared its final hurdle in Parliament and comes ...

Silicon Valley billionaires love to chase extreme health tech. Their next obsession, after dabbling in tech to reverse aging, ...

Origin Agritech Ltd., today announced it has entered into a patent license agreement with Shandong Shunfeng Biotechnology Co.

GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.

In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...